glp-1 medications approved for type 2 diabetes 2025 Is now the time to expand the benefits of people with 1? These new study results indicate that it is…in a new study presented at #ADASciSessions, Dr. Viral Complete Guide to GLP-1 Medications

performed a systematic review and meta-analysis of GLP-1-based therapies on MASLD/MASH outcomes, incorporating both clinical trials and real-world studies [63]

At baseline, participants were prescribed a range of GLP-1 RA, with semaglutide being the most commonly prescribed agent across both injectable and oral formulations (Table 1)

Waist circumference, progress photos, and if available, DEXA scans or body impedance measurements provide the fuller picture that before and after comparisons reveal

Semaglutide: Brand names Ozempic, Wegovy, and Rybelsus Ozempic and Rybelsus are FDA approved for T2DM and are held to the same criteria as Trulicity